CDX2: Difference between revisions
Jump to navigation
Jump to search
| Line 24: | Line 24: | ||
==Pathology== | ==Pathology== | ||
===Positive=== | ===Positive=== | ||
*Intestinal adenocarcinomas - | *Intestinal adenocarcinomas. | ||
*[[Ovarian mucinous adenocarcinoma]] | **[[Colorectal adenocarcinoma]] ~ 90% of cases.<ref name=pmid13679455/> | ||
====Sometimes positive==== | |||
*[[Stomach adenocarcinoma]] ~20-30% of cases.<ref name=pmid13679455/> | |||
*[[Esophageal adenocarcinoma]] ~20-30% of cases.<ref name=pmid13679455/> | |||
*[[Ovarian mucinous adenocarcinoma]]<ref name=pmid14668551/> ~20-30% of cases.<ref name=pmid13679455/> | |||
*[[Endometrioid endometrial adenocarcinoma]] ~20-30% of cases.<ref name=pmid13679455/> | |||
===Negative or positive=== | ===Negative or positive=== | ||